Globus Medical, Inc. (GMED) Stock Overview
Explore Globus Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Globus Medical, Inc. (GMED)
Key Financials
Key Financials
Market Cap
11.7B
P/E Ratio
21.80
EPS (TTM)
$4.44
ROE
0.12%
GMED Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Globus Medical, Inc. (NYSE: GMED) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Globus Medical, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of GMED on the NYSE shows an RSI of 60.05, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $94.80 for the NYSE listing.
Key metrics behind Globus Medical, Inc.'s NYSE-traded stock include a P/E ratio of 21.80 and a market capitalization of 11.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of GMED on the NYSE.